nasdaq:neo
|
https://www.indeed.com/cmp/neogenomics
|
Aug 29th, 2022 12:00AM
|
Open
|
NeoGenomics
|
|
Healthcare
|
NeoGenomics is a premier cancer diagnostics and pharma services company serving oncologists, pathologists, pharmaceutical companies, academic centers, and others with innovative diagnostic, prognostic and predictive testing. Our vision embodies uncompromising quality, exceptional service, and innovative solutions. We have a network of CAP-accredited, CLIA-certified facilities in the U.S., and offer global capabilities with laboratories in Switzerland, Singapore, and China.
NeoGenomics has been serving the cancer community for over 19 years, and each member of our team is committed to our mission: Save lives by improving patient care.
It all comes back to the patients. Time and results mean everything to our patients, and we keep that first in our minds.
|
RRv1_100M_500M
|
Fort Myers, FL
|
Chris Smith
|
|
|
3.40
|
58.0
|
62.0
|
66.0
|
60.0
|
53.0
|
51.0
|
53.0
|
59.0
|
55.0
|
56.0
|
51.0
|
61.0
|
64.0
|
95.0
|
125.00
|
125.00
|
3.20
|
3.50
|
3.10
|
2.90
|
3.30
|
37.00
|
About a week
|
42.00
|
MEDIUM
|
38.00
|
FAVORABLE
|
|
|
|
Aug 29th, 2022 12:20PM
|
Aug 29th, 2022 12:20PM
|
NeoGenomics
|
|
Health Care Equipment & Services
|
nasdaq:neo
|
https://www.indeed.com/cmp/neogenomics
|
Aug 28th, 2022 12:00AM
|
Open
|
NeoGenomics
|
|
Healthcare
|
NeoGenomics is a premier cancer diagnostics and pharma services company serving oncologists, pathologists, pharmaceutical companies, academic centers, and others with innovative diagnostic, prognostic and predictive testing. Our vision embodies uncompromising quality, exceptional service, and innovative solutions. We have a network of CAP-accredited, CLIA-certified facilities in the U.S., and offer global capabilities with laboratories in Switzerland, Singapore, and China.
NeoGenomics has been serving the cancer community for over 19 years, and each member of our team is committed to our mission: Save lives by improving patient care.
It all comes back to the patients. Time and results mean everything to our patients, and we keep that first in our minds.
|
RRv1_100M_500M
|
Fort Myers, FL
|
Chris Smith
|
|
|
3.40
|
58.0
|
62.0
|
66.0
|
60.0
|
53.0
|
51.0
|
53.0
|
59.0
|
55.0
|
56.0
|
51.0
|
61.0
|
64.0
|
95.0
|
125.00
|
125.00
|
3.20
|
3.50
|
3.10
|
2.90
|
3.30
|
37.00
|
About a week
|
42.00
|
MEDIUM
|
38.00
|
FAVORABLE
|
|
|
|
Aug 28th, 2022 05:19AM
|
Aug 28th, 2022 05:19AM
|
NeoGenomics
|
|
Health Care Equipment & Services
|
nasdaq:neo
|
https://www.indeed.com/cmp/neogenomics
|
Aug 27th, 2022 12:00AM
|
Open
|
NeoGenomics
|
|
Healthcare
|
NeoGenomics is a premier cancer diagnostics and pharma services company serving oncologists, pathologists, pharmaceutical companies, academic centers, and others with innovative diagnostic, prognostic and predictive testing. Our vision embodies uncompromising quality, exceptional service, and innovative solutions. We have a network of CAP-accredited, CLIA-certified facilities in the U.S., and offer global capabilities with laboratories in Switzerland, Singapore, and China.
NeoGenomics has been serving the cancer community for over 19 years, and each member of our team is committed to our mission: Save lives by improving patient care.
It all comes back to the patients. Time and results mean everything to our patients, and we keep that first in our minds.
|
RRv1_100M_500M
|
Fort Myers, FL
|
Chris Smith
|
|
|
3.40
|
58.0
|
62.0
|
66.0
|
60.0
|
53.0
|
51.0
|
53.0
|
59.0
|
55.0
|
56.0
|
51.0
|
61.0
|
64.0
|
95.0
|
125.00
|
125.00
|
3.20
|
3.50
|
3.10
|
2.90
|
3.30
|
37.00
|
About a week
|
42.00
|
MEDIUM
|
38.00
|
FAVORABLE
|
|
|
|
Aug 27th, 2022 04:38AM
|
Aug 27th, 2022 04:38AM
|
NeoGenomics
|
|
Health Care Equipment & Services
|
nasdaq:neo
|
https://www.indeed.com/cmp/neogenomics
|
Aug 25th, 2022 12:00AM
|
Open
|
NeoGenomics
|
|
Healthcare
|
NeoGenomics is a premier cancer diagnostics and pharma services company serving oncologists, pathologists, pharmaceutical companies, academic centers, and others with innovative diagnostic, prognostic and predictive testing. Our vision embodies uncompromising quality, exceptional service, and innovative solutions. We have a network of CAP-accredited, CLIA-certified facilities in the U.S., and offer global capabilities with laboratories in Switzerland, Singapore, and China.
NeoGenomics has been serving the cancer community for over 19 years, and each member of our team is committed to our mission: Save lives by improving patient care.
It all comes back to the patients. Time and results mean everything to our patients, and we keep that first in our minds.
|
RRv1_100M_500M
|
Fort Myers, FL
|
Chris Smith
|
|
|
3.40
|
58.0
|
62.0
|
66.0
|
60.0
|
53.0
|
51.0
|
53.0
|
59.0
|
55.0
|
56.0
|
51.0
|
61.0
|
64.0
|
95.0
|
123.00
|
123.00
|
3.20
|
3.50
|
3.10
|
2.90
|
3.30
|
37.00
|
About a week
|
42.00
|
MEDIUM
|
38.00
|
FAVORABLE
|
|
|
|
Aug 25th, 2022 09:18AM
|
Aug 25th, 2022 09:18AM
|
NeoGenomics
|
|
Health Care Equipment & Services
|
nasdaq:neo
|
https://www.indeed.com/cmp/neogenomics
|
Aug 23rd, 2022 12:00AM
|
Open
|
NeoGenomics
|
|
Healthcare
|
NeoGenomics is a premier cancer diagnostics and pharma services company serving oncologists, pathologists, pharmaceutical companies, academic centers, and others with innovative diagnostic, prognostic and predictive testing. Our vision embodies uncompromising quality, exceptional service, and innovative solutions. We have a network of CAP-accredited, CLIA-certified facilities in the U.S., and offer global capabilities with laboratories in Switzerland, Singapore, and China.
NeoGenomics has been serving the cancer community for over 19 years, and each member of our team is committed to our mission: Save lives by improving patient care.
It all comes back to the patients. Time and results mean everything to our patients, and we keep that first in our minds.
|
RRv1_100M_500M
|
Fort Myers, FL
|
Chris Smith
|
|
|
3.40
|
58.0
|
62.0
|
66.0
|
60.0
|
53.0
|
51.0
|
53.0
|
59.0
|
55.0
|
56.0
|
51.0
|
61.0
|
64.0
|
95.0
|
123.00
|
123.00
|
3.20
|
3.50
|
3.10
|
2.90
|
3.30
|
37.00
|
About a week
|
42.00
|
MEDIUM
|
38.00
|
FAVORABLE
|
|
|
|
Aug 23rd, 2022 11:11AM
|
Aug 23rd, 2022 11:11AM
|
NeoGenomics
|
|
Health Care Equipment & Services
|
nasdaq:neo
|
https://www.indeed.com/cmp/neogenomics
|
Aug 21st, 2022 12:00AM
|
Open
|
NeoGenomics
|
|
Healthcare
|
NeoGenomics is a premier cancer diagnostics and pharma services company serving oncologists, pathologists, pharmaceutical companies, academic centers, and others with innovative diagnostic, prognostic and predictive testing. Our vision embodies uncompromising quality, exceptional service, and innovative solutions. We have a network of CAP-accredited, CLIA-certified facilities in the U.S., and offer global capabilities with laboratories in Switzerland, Singapore, and China.
NeoGenomics has been serving the cancer community for over 19 years, and each member of our team is committed to our mission: Save lives by improving patient care.
It all comes back to the patients. Time and results mean everything to our patients, and we keep that first in our minds.
|
RRv1_100M_500M
|
Fort Myers, FL
|
Chris Smith
|
|
|
3.40
|
58.0
|
62.0
|
66.0
|
60.0
|
53.0
|
51.0
|
53.0
|
59.0
|
55.0
|
56.0
|
|
61.0
|
64.0
|
95.0
|
123.00
|
123.00
|
3.20
|
3.50
|
3.10
|
2.90
|
3.30
|
36.00
|
About a week
|
41.00
|
MEDIUM
|
38.00
|
FAVORABLE
|
|
|
|
Aug 21st, 2022 12:55PM
|
Aug 21st, 2022 12:55PM
|
NeoGenomics
|
|
Health Care Equipment & Services
|
nasdaq:neo
|
https://www.indeed.com/cmp/neogenomics
|
Aug 20th, 2022 12:00AM
|
Open
|
NeoGenomics
|
|
Healthcare
|
NeoGenomics is a premier cancer diagnostics and pharma services company serving oncologists, pathologists, pharmaceutical companies, academic centers, and others with innovative diagnostic, prognostic and predictive testing. Our vision embodies uncompromising quality, exceptional service, and innovative solutions. We have a network of CAP-accredited, CLIA-certified facilities in the U.S., and offer global capabilities with laboratories in Switzerland, Singapore, and China.
NeoGenomics has been serving the cancer community for over 19 years, and each member of our team is committed to our mission: Save lives by improving patient care.
It all comes back to the patients. Time and results mean everything to our patients, and we keep that first in our minds.
|
RRv1_100M_500M
|
Fort Myers, FL
|
Chris Smith
|
|
|
3.40
|
58.0
|
62.0
|
66.0
|
60.0
|
53.0
|
51.0
|
53.0
|
59.0
|
55.0
|
56.0
|
51.0
|
61.0
|
64.0
|
95.0
|
123.00
|
123.00
|
3.20
|
3.50
|
3.10
|
2.90
|
3.30
|
36.00
|
About a week
|
41.00
|
MEDIUM
|
38.00
|
FAVORABLE
|
|
|
|
Aug 20th, 2022 02:32PM
|
Aug 20th, 2022 02:32PM
|
NeoGenomics
|
|
Health Care Equipment & Services
|
nasdaq:neo
|
https://www.indeed.com/cmp/neogenomics
|
Aug 19th, 2022 12:00AM
|
Open
|
NeoGenomics
|
|
Healthcare
|
NeoGenomics is a premier cancer diagnostics and pharma services company serving oncologists, pathologists, pharmaceutical companies, academic centers, and others with innovative diagnostic, prognostic and predictive testing. Our vision embodies uncompromising quality, exceptional service, and innovative solutions. We have a network of CAP-accredited, CLIA-certified facilities in the U.S., and offer global capabilities with laboratories in Switzerland, Singapore, and China.
NeoGenomics has been serving the cancer community for over 19 years, and each member of our team is committed to our mission: Save lives by improving patient care.
It all comes back to the patients. Time and results mean everything to our patients, and we keep that first in our minds.
|
RRv1_100M_500M
|
Fort Myers, FL
|
Chris Smith
|
|
|
3.40
|
58.0
|
62.0
|
66.0
|
60.0
|
53.0
|
51.0
|
53.0
|
59.0
|
55.0
|
56.0
|
51.0
|
61.0
|
64.0
|
95.0
|
123.00
|
123.00
|
3.20
|
3.50
|
3.10
|
2.90
|
3.30
|
36.00
|
About a week
|
41.00
|
MEDIUM
|
38.00
|
FAVORABLE
|
|
|
|
Aug 19th, 2022 12:55PM
|
Aug 19th, 2022 12:55PM
|
NeoGenomics
|
|
Health Care Equipment & Services
|
nasdaq:neo
|
https://www.indeed.com/cmp/neogenomics
|
Aug 18th, 2022 12:00AM
|
Open
|
NeoGenomics
|
|
Healthcare
|
NeoGenomics is a premier cancer diagnostics and pharma services company serving oncologists, pathologists, pharmaceutical companies, academic centers, and others with innovative diagnostic, prognostic and predictive testing. Our vision embodies uncompromising quality, exceptional service, and innovative solutions. We have a network of CAP-accredited, CLIA-certified facilities in the U.S., and offer global capabilities with laboratories in Switzerland, Singapore, and China.
NeoGenomics has been serving the cancer community for over 19 years, and each member of our team is committed to our mission: Save lives by improving patient care.
It all comes back to the patients. Time and results mean everything to our patients, and we keep that first in our minds.
|
RRv1_100M_500M
|
Fort Myers, FL
|
Chris Smith
|
|
|
3.40
|
57.0
|
62.0
|
66.0
|
60.0
|
53.0
|
51.0
|
53.0
|
59.0
|
55.0
|
56.0
|
51.0
|
61.0
|
64.0
|
95.0
|
123.00
|
123.00
|
3.20
|
3.50
|
3.10
|
2.90
|
3.30
|
36.00
|
About a week
|
41.00
|
MEDIUM
|
38.00
|
FAVORABLE
|
|
|
|
Aug 18th, 2022 04:39AM
|
Aug 18th, 2022 04:39AM
|
NeoGenomics
|
|
Health Care Equipment & Services
|
nasdaq:neo
|
https://www.indeed.com/cmp/neogenomics
|
Aug 17th, 2022 12:00AM
|
Open
|
NeoGenomics
|
|
Healthcare
|
NeoGenomics is a premier cancer diagnostics and pharma services company serving oncologists, pathologists, pharmaceutical companies, academic centers, and others with innovative diagnostic, prognostic and predictive testing. Our vision embodies uncompromising quality, exceptional service, and innovative solutions. We have a network of CAP-accredited, CLIA-certified facilities in the U.S., and offer global capabilities with laboratories in Switzerland, Singapore, and China.
NeoGenomics has been serving the cancer community for over 19 years, and each member of our team is committed to our mission: Save lives by improving patient care.
It all comes back to the patients. Time and results mean everything to our patients, and we keep that first in our minds.
|
RRv1_100M_500M
|
Fort Myers, FL
|
Chris Smith
|
|
|
3.40
|
58.0
|
62.0
|
66.0
|
61.0
|
53.0
|
51.0
|
54.0
|
59.0
|
55.0
|
56.0
|
51.0
|
61.0
|
64.0
|
94.0
|
123.00
|
123.00
|
3.20
|
3.50
|
3.10
|
2.90
|
3.30
|
36.00
|
About a week
|
41.00
|
MEDIUM
|
38.00
|
FAVORABLE
|
|
|
|
Aug 17th, 2022 10:18AM
|
Aug 17th, 2022 10:18AM
|
NeoGenomics
|
|
Health Care Equipment & Services
|